CVE-2026-9844

CVE-2026-9844 is a high-severity vulnerability with a CVSS 4.0 base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-1392.

Key facts

Description

Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.

Frequently asked questions

What is CVE-2026-9844?
Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.
How severe is CVE-2026-9844?
CVE-2026-9844 has a CVSS 4.0 base score of 8.8, rated high severity.
Is CVE-2026-9844 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (15th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2026-9844?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2026-9844 have an EU (EUVD) identifier?
Yes. CVE-2026-9844 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-33923.
When was CVE-2026-9844 published?
CVE-2026-9844 was published on 2026-06-02 and last updated on 2026-06-17.

References

Other CWE-1392 vulnerabilities

Browse all CWE-1392 vulnerabilities →